Dr. Brian C. Myre
Claim this profileElmhurst Memorial Hospital
Studies Cancer
Studies Renal Cell Carcinoma
7 reported clinical trials
28 drugs studied
Affiliated Hospitals
Clinical Trials Brian C. Myre is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
More about Brian C. Myre
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brian C. Myre has experience with
- Atezolizumab
- Radiation Therapy
- Nivolumab
- Ipilimumab
- Cisplatin
- Apalutamide
Breakdown of trials Brian C. Myre has run
Cancer
Renal Cell Carcinoma
Tumors
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian C. Myre specialize in?
Brian C. Myre focuses on Cancer and Renal Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Brian C. Myre currently recruiting for clinical trials?
Yes, Brian C. Myre is currently recruiting for 4 clinical trials in Elmhurst Illinois. If you're interested in participating, you should apply.
Are there any treatments that Brian C. Myre has studied deeply?
Yes, Brian C. Myre has studied treatments such as Atezolizumab, Radiation Therapy, Nivolumab.
What is the best way to schedule an appointment with Brian C. Myre?
Apply for one of the trials that Brian C. Myre is conducting.
What is the office address of Brian C. Myre?
The office of Brian C. Myre is located at: Elmhurst Memorial Hospital, Elmhurst, Illinois 60126 United States. This is the address for their practice at the Elmhurst Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.